mutation NUMBER flanking region gene reported associated chronic obstructive pulmonary disease copd investigated prevalence mutation group NUMBER patients airway obstruction NUMBER controls subjects selected basis development lung cancer similar exposure cigarette smoke major risk factor copd majority subjects level airway inflammation loss elastic recoil known able test mutation associated pathological mechanisms prevalence heterozygotes mutation NUMBER obstructed group controls mutation associated increased airway inflammation loss elastic recoil result indicates NUMBER mutation significant risk factor copd population suggests heterogeneity pathogenesis disease alpha NUMBER antitrypsin non obstructed